Influence of 18F-FDG PET/CT on therapy management in patients with stage III/IV malignant melanoma View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2016-03

AUTHORS

Susann-Cathrin Schüle, Thomas Kurt Eigentler, Claus Garbe, Christian la Fougère, Konstantin Nikolaou, Christina Pfannenberg

ABSTRACT

PURPOSE: To evaluate the influence of (18)F-FDG PET/CT in comparison to CT alone on treatment decisions in patients with advanced melanoma and to analyse the 5-year survival data in comparison to literature data. METHODS: Therapy management in 64 consecutive patients (primary staging n = 52; surveillance n = 12) with stage III/IV melanoma who underwent (18)F-FDG PET/CT between 2004 and 2005 in our department was retrospectively analysed. Treatment decisions were made by two dermatooncologists for each patient twice, first based on the CT results and then based on the PET/CT results. Therapy changes based on the PET/CT results were classified as "major" (e.g. change from metastasectomy to systemic therapy) or "minor" (e.g. change from first to second line chemotherapy). The 5-year survival data of different patient cohorts were calculated. RESULTS: In the 52 patients in the primary staging group, the results of (18)F-FDG PET/CT led to therapy change in 59% and a major therapy change in 52%. (18)F-FDG PET/CT led to the avoidance of futile operations in 13 patients with suspicious lesions on CT that were deemed nontumorous on PET/CT. In the 12 patients in the surveillance group, the results of (18)F-FDG PET/CT led to therapy change in 33% and a major change in 17%. The 5-year survival rates were 30% in the entire cohort, 34% in the primary staging group, and 17% in the surveillance group. A significant overall survival benefit was observed in patients in whom (18)F-FDG PET/CT excluded metastases or in whom metastases could be completely removed compared with patients who were not eligible for surgery (41% vs. 10%). CONCLUSION: Primary staging of patients with stage III/IV melanoma should be performed with (18)F-FDG PET/CT, leading to higher diagnostic accuracy and enabling individualized therapeutic management, especially optimal patient selection for metastasectomy. This strategy may extend long-term survival even in patients with advanced disease. More... »

PAGES

482-488

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s00259-015-3187-2

DOI

http://dx.doi.org/10.1007/s00259-015-3187-2

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1018897152

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/26384681


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Decision Making", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Fluorodeoxyglucose F18", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Kaplan-Meier Estimate", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Melanoma", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Multimodal Imaging", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neoplasm Metastasis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neoplasm Staging", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Positron-Emission Tomography", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Radiopharmaceuticals", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Retrospective Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Skin Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Tomography, X-Ray Computed", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Treatment Outcome", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Young Adult", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "University of T\u00fcbingen", 
          "id": "https://www.grid.ac/institutes/grid.10392.39", 
          "name": [
            "Department of Diagnostic and Interventional Radiology, Eberhard-Karls-University Tuebingen, Hoppe-Seyler-Strasse 3, 72076, Tuebingen, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Sch\u00fcle", 
        "givenName": "Susann-Cathrin", 
        "id": "sg:person.0657364006.01", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0657364006.01"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of T\u00fcbingen", 
          "id": "https://www.grid.ac/institutes/grid.10392.39", 
          "name": [
            "Skin Cancer Programme, Department of Dermatology, Eberhard-Karls-University Tuebingen, Tuebingen, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Eigentler", 
        "givenName": "Thomas Kurt", 
        "id": "sg:person.01200444654.37", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01200444654.37"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of T\u00fcbingen", 
          "id": "https://www.grid.ac/institutes/grid.10392.39", 
          "name": [
            "Skin Cancer Programme, Department of Dermatology, Eberhard-Karls-University Tuebingen, Tuebingen, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Garbe", 
        "givenName": "Claus", 
        "id": "sg:person.01221773122.43", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01221773122.43"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of T\u00fcbingen", 
          "id": "https://www.grid.ac/institutes/grid.10392.39", 
          "name": [
            "Department of Nuclear Medicine, Eberhard-Karls-University Tuebingen, Tuebingen, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "la Foug\u00e8re", 
        "givenName": "Christian", 
        "id": "sg:person.01026465143.13", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01026465143.13"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of T\u00fcbingen", 
          "id": "https://www.grid.ac/institutes/grid.10392.39", 
          "name": [
            "Department of Diagnostic and Interventional Radiology, Eberhard-Karls-University Tuebingen, Hoppe-Seyler-Strasse 3, 72076, Tuebingen, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Nikolaou", 
        "givenName": "Konstantin", 
        "id": "sg:person.0626217515.03", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0626217515.03"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of T\u00fcbingen", 
          "id": "https://www.grid.ac/institutes/grid.10392.39", 
          "name": [
            "Department of Diagnostic and Interventional Radiology, Eberhard-Karls-University Tuebingen, Hoppe-Seyler-Strasse 3, 72076, Tuebingen, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Pfannenberg", 
        "givenName": "Christina", 
        "id": "sg:person.0740477320.84", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0740477320.84"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1056/nejmoa1408868", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000859328"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00117-014-2762-z", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003985269", 
          "https://doi.org/10.1007/s00117-014-2762-z"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.soc.2010.09.010", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004241026"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmra041245", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005930121"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ejrad.2009.04.059", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1009451175"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa1412082", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1012352031"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2009.23.4799", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1013277178"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/cmr.0b013e3283632cbe", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1015048128"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/cmr.0b013e3283632cbe", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1015048128"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ejca.2006.11.014", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1028226511"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1610-0387.2011.07614.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034453469"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1245/s10434-012-2398-z", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1036889506", 
          "https://doi.org/10.1245/s10434-012-2398-z"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/cmr.0000000000000076", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037079313"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/cmr.0000000000000076", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037079313"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/jnci/djq455", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038901158"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa1103782", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1041864150"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/ddg.12113_suppl", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1043401358"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1245/s10434-012-2399-y", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1047443051", 
          "https://doi.org/10.1245/s10434-012-2399-y"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa1406037", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1047704810"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1053/j.semnuclmed.2015.03.006", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1048724551"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/bjc.2012.306", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1051259551", 
          "https://doi.org/10.1038/bjc.2012.306"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa1203421", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1051983710"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa1003466", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052212829"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s1010-7940(02)00026-x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1054669694"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2214/ajr.11.7280", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1069301940"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1078834270", 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2016-03", 
    "datePublishedReg": "2016-03-01", 
    "description": "PURPOSE: To evaluate the influence of (18)F-FDG PET/CT in comparison to CT alone on treatment decisions in patients with advanced melanoma and to analyse the 5-year survival data in comparison to literature data.\nMETHODS: Therapy management in 64 consecutive patients (primary staging n\u2009=\u200952; surveillance n\u2009=\u200912) with stage III/IV melanoma who underwent (18)F-FDG PET/CT between 2004 and 2005 in our department was retrospectively analysed. Treatment decisions were made by two dermatooncologists for each patient twice, first based on the CT results and then based on the PET/CT results. Therapy changes based on the PET/CT results were classified as \"major\" (e.g. change from metastasectomy to systemic therapy) or \"minor\" (e.g. change from first to second line chemotherapy). The 5-year survival data of different patient cohorts were calculated.\nRESULTS: In the 52 patients in the primary staging group, the results of (18)F-FDG PET/CT led to therapy change in 59% and a major therapy change in 52%. (18)F-FDG PET/CT led to the avoidance of futile operations in 13 patients with suspicious lesions on CT that were deemed nontumorous on PET/CT. In the 12 patients in the surveillance group, the results of (18)F-FDG PET/CT led to therapy change in 33% and a major change in 17%. The 5-year survival rates were 30% in the entire cohort, 34% in the primary staging group, and 17% in the surveillance group. A significant overall survival benefit was observed in patients in whom (18)F-FDG PET/CT excluded metastases or in whom metastases could be completely removed compared with patients who were not eligible for surgery (41% vs. 10%).\nCONCLUSION: Primary staging of patients with stage III/IV melanoma should be performed with (18)F-FDG PET/CT, leading to higher diagnostic accuracy and enabling individualized therapeutic management, especially optimal patient selection for metastasectomy. This strategy may extend long-term survival even in patients with advanced disease.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/s00259-015-3187-2", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1297401", 
        "issn": [
          "1619-7070", 
          "1619-7089"
        ], 
        "name": "European Journal of Nuclear Medicine and Molecular Imaging", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "3", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "43"
      }
    ], 
    "name": "Influence of 18F-FDG PET/CT on therapy management in patients with stage III/IV malignant melanoma", 
    "pagination": "482-488", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "5a0a2b76504329a953ae39a0dc8e557da16626a1f4a380b1c6e3cd727968f57e"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "26384681"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "101140988"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s00259-015-3187-2"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1018897152"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s00259-015-3187-2", 
      "https://app.dimensions.ai/details/publication/pub.1018897152"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T02:00", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8700_00000512.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.1007%2Fs00259-015-3187-2"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s00259-015-3187-2'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s00259-015-3187-2'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s00259-015-3187-2'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s00259-015-3187-2'


 

This table displays all metadata directly associated to this object as RDF triples.

261 TRIPLES      21 PREDICATES      73 URIs      41 LITERALS      29 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s00259-015-3187-2 schema:about N1c6421c9b0e64932b1de2d7b98d5c50d
2 N25996b0c5efa4c6f975f2a75beaf70b8
3 N2b17efd0ca6748c1b747b2c589114f51
4 N4f31968513f94529b9addb8925268673
5 N79b89767988e48a38930fc4611ff8d85
6 N7a54c94a4ca3431c9eb83261933ca3e9
7 N7dccec192e2a4add81ee8be1dad246a0
8 N8084fbedcb4b4cb38f29220fa03fb98b
9 N8bde9c3b29394efda4ea817a6beabb87
10 N942a9fbd16b74b2e8cf0a0bb02ff5b11
11 Na6b7b65758294b988a2d31c15d8b223a
12 Nb255ef6894c146c3acc4093d0f974eef
13 Nb6002bf4941441dbb4abdb5f94ac4f76
14 Ndbc1090945c844f583a63e54a9012a45
15 Ndc786bc2753644e7ac4f85cb1a5f80fd
16 Ne22e7cb7bfa4450abc70b20fe6ebc2bc
17 Ne741e2d2e29747d7bb8ee3ecab7bd61d
18 Neb037aaf8c2541dd9fe44518411f3cac
19 Nedbf2b5ee92848339f64fdf98304ca35
20 Nf4e185090e0f4a78a94bab2b9a93a6d5
21 anzsrc-for:11
22 anzsrc-for:1112
23 schema:author N9fe033fbd977430bbdc12d434681d675
24 schema:citation sg:pub.10.1007/s00117-014-2762-z
25 sg:pub.10.1038/bjc.2012.306
26 sg:pub.10.1245/s10434-012-2398-z
27 sg:pub.10.1245/s10434-012-2399-y
28 https://app.dimensions.ai/details/publication/pub.1078834270
29 https://doi.org/10.1016/j.ejca.2006.11.014
30 https://doi.org/10.1016/j.ejrad.2009.04.059
31 https://doi.org/10.1016/j.soc.2010.09.010
32 https://doi.org/10.1016/s1010-7940(02)00026-x
33 https://doi.org/10.1053/j.semnuclmed.2015.03.006
34 https://doi.org/10.1056/nejmoa1003466
35 https://doi.org/10.1056/nejmoa1103782
36 https://doi.org/10.1056/nejmoa1203421
37 https://doi.org/10.1056/nejmoa1406037
38 https://doi.org/10.1056/nejmoa1408868
39 https://doi.org/10.1056/nejmoa1412082
40 https://doi.org/10.1056/nejmra041245
41 https://doi.org/10.1093/jnci/djq455
42 https://doi.org/10.1097/cmr.0000000000000076
43 https://doi.org/10.1097/cmr.0b013e3283632cbe
44 https://doi.org/10.1111/ddg.12113_suppl
45 https://doi.org/10.1111/j.1610-0387.2011.07614.x
46 https://doi.org/10.1200/jco.2009.23.4799
47 https://doi.org/10.2214/ajr.11.7280
48 schema:datePublished 2016-03
49 schema:datePublishedReg 2016-03-01
50 schema:description PURPOSE: To evaluate the influence of (18)F-FDG PET/CT in comparison to CT alone on treatment decisions in patients with advanced melanoma and to analyse the 5-year survival data in comparison to literature data. METHODS: Therapy management in 64 consecutive patients (primary staging n = 52; surveillance n = 12) with stage III/IV melanoma who underwent (18)F-FDG PET/CT between 2004 and 2005 in our department was retrospectively analysed. Treatment decisions were made by two dermatooncologists for each patient twice, first based on the CT results and then based on the PET/CT results. Therapy changes based on the PET/CT results were classified as "major" (e.g. change from metastasectomy to systemic therapy) or "minor" (e.g. change from first to second line chemotherapy). The 5-year survival data of different patient cohorts were calculated. RESULTS: In the 52 patients in the primary staging group, the results of (18)F-FDG PET/CT led to therapy change in 59% and a major therapy change in 52%. (18)F-FDG PET/CT led to the avoidance of futile operations in 13 patients with suspicious lesions on CT that were deemed nontumorous on PET/CT. In the 12 patients in the surveillance group, the results of (18)F-FDG PET/CT led to therapy change in 33% and a major change in 17%. The 5-year survival rates were 30% in the entire cohort, 34% in the primary staging group, and 17% in the surveillance group. A significant overall survival benefit was observed in patients in whom (18)F-FDG PET/CT excluded metastases or in whom metastases could be completely removed compared with patients who were not eligible for surgery (41% vs. 10%). CONCLUSION: Primary staging of patients with stage III/IV melanoma should be performed with (18)F-FDG PET/CT, leading to higher diagnostic accuracy and enabling individualized therapeutic management, especially optimal patient selection for metastasectomy. This strategy may extend long-term survival even in patients with advanced disease.
51 schema:genre research_article
52 schema:inLanguage en
53 schema:isAccessibleForFree false
54 schema:isPartOf N27c871dafcfb4a98bdc9aca7bf9b55fe
55 N612bfa9ccba1441aa4c452f00ea830ee
56 sg:journal.1297401
57 schema:name Influence of 18F-FDG PET/CT on therapy management in patients with stage III/IV malignant melanoma
58 schema:pagination 482-488
59 schema:productId N05e8078a736b4eeda4b66cac4e820646
60 N88461a133a8744de95cbafa457f29e10
61 N8df28c5df3c84b7b999829e6cd18eac8
62 Nc907bc3a3c04468195627eba9f088b0a
63 Nfcbc2f09ecd649f8a5c585f97fe40d9f
64 schema:sameAs https://app.dimensions.ai/details/publication/pub.1018897152
65 https://doi.org/10.1007/s00259-015-3187-2
66 schema:sdDatePublished 2019-04-11T02:00
67 schema:sdLicense https://scigraph.springernature.com/explorer/license/
68 schema:sdPublisher Nd4b1c29a6fde4f0c94a5725a50e62c4e
69 schema:url http://link.springer.com/10.1007%2Fs00259-015-3187-2
70 sgo:license sg:explorer/license/
71 sgo:sdDataset articles
72 rdf:type schema:ScholarlyArticle
73 N05e8078a736b4eeda4b66cac4e820646 schema:name pubmed_id
74 schema:value 26384681
75 rdf:type schema:PropertyValue
76 N12a52a6434e640e784fa2fbb95b5dd7d rdf:first sg:person.01200444654.37
77 rdf:rest Nde4b4fafd1794d359f716c24ef3b5436
78 N13a0b363e87045188d4a03f40d1ebb57 rdf:first sg:person.0740477320.84
79 rdf:rest rdf:nil
80 N1c6421c9b0e64932b1de2d7b98d5c50d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
81 schema:name Kaplan-Meier Estimate
82 rdf:type schema:DefinedTerm
83 N1fbade7a08ec43348ee7cba4ccd7cbb2 rdf:first sg:person.01026465143.13
84 rdf:rest N7b7e7ef2536b48f0a12f63adaa53d034
85 N25996b0c5efa4c6f975f2a75beaf70b8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
86 schema:name Male
87 rdf:type schema:DefinedTerm
88 N27c871dafcfb4a98bdc9aca7bf9b55fe schema:volumeNumber 43
89 rdf:type schema:PublicationVolume
90 N2b17efd0ca6748c1b747b2c589114f51 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
91 schema:name Tomography, X-Ray Computed
92 rdf:type schema:DefinedTerm
93 N4f31968513f94529b9addb8925268673 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
94 schema:name Melanoma
95 rdf:type schema:DefinedTerm
96 N612bfa9ccba1441aa4c452f00ea830ee schema:issueNumber 3
97 rdf:type schema:PublicationIssue
98 N79b89767988e48a38930fc4611ff8d85 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
99 schema:name Multimodal Imaging
100 rdf:type schema:DefinedTerm
101 N7a54c94a4ca3431c9eb83261933ca3e9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
102 schema:name Fluorodeoxyglucose F18
103 rdf:type schema:DefinedTerm
104 N7b7e7ef2536b48f0a12f63adaa53d034 rdf:first sg:person.0626217515.03
105 rdf:rest N13a0b363e87045188d4a03f40d1ebb57
106 N7dccec192e2a4add81ee8be1dad246a0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
107 schema:name Humans
108 rdf:type schema:DefinedTerm
109 N8084fbedcb4b4cb38f29220fa03fb98b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
110 schema:name Decision Making
111 rdf:type schema:DefinedTerm
112 N88461a133a8744de95cbafa457f29e10 schema:name nlm_unique_id
113 schema:value 101140988
114 rdf:type schema:PropertyValue
115 N8bde9c3b29394efda4ea817a6beabb87 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
116 schema:name Retrospective Studies
117 rdf:type schema:DefinedTerm
118 N8df28c5df3c84b7b999829e6cd18eac8 schema:name readcube_id
119 schema:value 5a0a2b76504329a953ae39a0dc8e557da16626a1f4a380b1c6e3cd727968f57e
120 rdf:type schema:PropertyValue
121 N942a9fbd16b74b2e8cf0a0bb02ff5b11 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
122 schema:name Treatment Outcome
123 rdf:type schema:DefinedTerm
124 N9fe033fbd977430bbdc12d434681d675 rdf:first sg:person.0657364006.01
125 rdf:rest N12a52a6434e640e784fa2fbb95b5dd7d
126 Na6b7b65758294b988a2d31c15d8b223a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
127 schema:name Positron-Emission Tomography
128 rdf:type schema:DefinedTerm
129 Nb255ef6894c146c3acc4093d0f974eef schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
130 schema:name Middle Aged
131 rdf:type schema:DefinedTerm
132 Nb6002bf4941441dbb4abdb5f94ac4f76 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
133 schema:name Skin Neoplasms
134 rdf:type schema:DefinedTerm
135 Nc907bc3a3c04468195627eba9f088b0a schema:name doi
136 schema:value 10.1007/s00259-015-3187-2
137 rdf:type schema:PropertyValue
138 Nd4b1c29a6fde4f0c94a5725a50e62c4e schema:name Springer Nature - SN SciGraph project
139 rdf:type schema:Organization
140 Ndbc1090945c844f583a63e54a9012a45 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
141 schema:name Young Adult
142 rdf:type schema:DefinedTerm
143 Ndc786bc2753644e7ac4f85cb1a5f80fd schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
144 schema:name Adult
145 rdf:type schema:DefinedTerm
146 Nde4b4fafd1794d359f716c24ef3b5436 rdf:first sg:person.01221773122.43
147 rdf:rest N1fbade7a08ec43348ee7cba4ccd7cbb2
148 Ne22e7cb7bfa4450abc70b20fe6ebc2bc schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
149 schema:name Neoplasm Metastasis
150 rdf:type schema:DefinedTerm
151 Ne741e2d2e29747d7bb8ee3ecab7bd61d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
152 schema:name Female
153 rdf:type schema:DefinedTerm
154 Neb037aaf8c2541dd9fe44518411f3cac schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
155 schema:name Aged
156 rdf:type schema:DefinedTerm
157 Nedbf2b5ee92848339f64fdf98304ca35 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
158 schema:name Neoplasm Staging
159 rdf:type schema:DefinedTerm
160 Nf4e185090e0f4a78a94bab2b9a93a6d5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
161 schema:name Radiopharmaceuticals
162 rdf:type schema:DefinedTerm
163 Nfcbc2f09ecd649f8a5c585f97fe40d9f schema:name dimensions_id
164 schema:value pub.1018897152
165 rdf:type schema:PropertyValue
166 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
167 schema:name Medical and Health Sciences
168 rdf:type schema:DefinedTerm
169 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
170 schema:name Oncology and Carcinogenesis
171 rdf:type schema:DefinedTerm
172 sg:journal.1297401 schema:issn 1619-7070
173 1619-7089
174 schema:name European Journal of Nuclear Medicine and Molecular Imaging
175 rdf:type schema:Periodical
176 sg:person.01026465143.13 schema:affiliation https://www.grid.ac/institutes/grid.10392.39
177 schema:familyName la Fougère
178 schema:givenName Christian
179 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01026465143.13
180 rdf:type schema:Person
181 sg:person.01200444654.37 schema:affiliation https://www.grid.ac/institutes/grid.10392.39
182 schema:familyName Eigentler
183 schema:givenName Thomas Kurt
184 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01200444654.37
185 rdf:type schema:Person
186 sg:person.01221773122.43 schema:affiliation https://www.grid.ac/institutes/grid.10392.39
187 schema:familyName Garbe
188 schema:givenName Claus
189 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01221773122.43
190 rdf:type schema:Person
191 sg:person.0626217515.03 schema:affiliation https://www.grid.ac/institutes/grid.10392.39
192 schema:familyName Nikolaou
193 schema:givenName Konstantin
194 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0626217515.03
195 rdf:type schema:Person
196 sg:person.0657364006.01 schema:affiliation https://www.grid.ac/institutes/grid.10392.39
197 schema:familyName Schüle
198 schema:givenName Susann-Cathrin
199 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0657364006.01
200 rdf:type schema:Person
201 sg:person.0740477320.84 schema:affiliation https://www.grid.ac/institutes/grid.10392.39
202 schema:familyName Pfannenberg
203 schema:givenName Christina
204 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0740477320.84
205 rdf:type schema:Person
206 sg:pub.10.1007/s00117-014-2762-z schema:sameAs https://app.dimensions.ai/details/publication/pub.1003985269
207 https://doi.org/10.1007/s00117-014-2762-z
208 rdf:type schema:CreativeWork
209 sg:pub.10.1038/bjc.2012.306 schema:sameAs https://app.dimensions.ai/details/publication/pub.1051259551
210 https://doi.org/10.1038/bjc.2012.306
211 rdf:type schema:CreativeWork
212 sg:pub.10.1245/s10434-012-2398-z schema:sameAs https://app.dimensions.ai/details/publication/pub.1036889506
213 https://doi.org/10.1245/s10434-012-2398-z
214 rdf:type schema:CreativeWork
215 sg:pub.10.1245/s10434-012-2399-y schema:sameAs https://app.dimensions.ai/details/publication/pub.1047443051
216 https://doi.org/10.1245/s10434-012-2399-y
217 rdf:type schema:CreativeWork
218 https://app.dimensions.ai/details/publication/pub.1078834270 schema:CreativeWork
219 https://doi.org/10.1016/j.ejca.2006.11.014 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028226511
220 rdf:type schema:CreativeWork
221 https://doi.org/10.1016/j.ejrad.2009.04.059 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009451175
222 rdf:type schema:CreativeWork
223 https://doi.org/10.1016/j.soc.2010.09.010 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004241026
224 rdf:type schema:CreativeWork
225 https://doi.org/10.1016/s1010-7940(02)00026-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1054669694
226 rdf:type schema:CreativeWork
227 https://doi.org/10.1053/j.semnuclmed.2015.03.006 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048724551
228 rdf:type schema:CreativeWork
229 https://doi.org/10.1056/nejmoa1003466 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052212829
230 rdf:type schema:CreativeWork
231 https://doi.org/10.1056/nejmoa1103782 schema:sameAs https://app.dimensions.ai/details/publication/pub.1041864150
232 rdf:type schema:CreativeWork
233 https://doi.org/10.1056/nejmoa1203421 schema:sameAs https://app.dimensions.ai/details/publication/pub.1051983710
234 rdf:type schema:CreativeWork
235 https://doi.org/10.1056/nejmoa1406037 schema:sameAs https://app.dimensions.ai/details/publication/pub.1047704810
236 rdf:type schema:CreativeWork
237 https://doi.org/10.1056/nejmoa1408868 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000859328
238 rdf:type schema:CreativeWork
239 https://doi.org/10.1056/nejmoa1412082 schema:sameAs https://app.dimensions.ai/details/publication/pub.1012352031
240 rdf:type schema:CreativeWork
241 https://doi.org/10.1056/nejmra041245 schema:sameAs https://app.dimensions.ai/details/publication/pub.1005930121
242 rdf:type schema:CreativeWork
243 https://doi.org/10.1093/jnci/djq455 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038901158
244 rdf:type schema:CreativeWork
245 https://doi.org/10.1097/cmr.0000000000000076 schema:sameAs https://app.dimensions.ai/details/publication/pub.1037079313
246 rdf:type schema:CreativeWork
247 https://doi.org/10.1097/cmr.0b013e3283632cbe schema:sameAs https://app.dimensions.ai/details/publication/pub.1015048128
248 rdf:type schema:CreativeWork
249 https://doi.org/10.1111/ddg.12113_suppl schema:sameAs https://app.dimensions.ai/details/publication/pub.1043401358
250 rdf:type schema:CreativeWork
251 https://doi.org/10.1111/j.1610-0387.2011.07614.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1034453469
252 rdf:type schema:CreativeWork
253 https://doi.org/10.1200/jco.2009.23.4799 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013277178
254 rdf:type schema:CreativeWork
255 https://doi.org/10.2214/ajr.11.7280 schema:sameAs https://app.dimensions.ai/details/publication/pub.1069301940
256 rdf:type schema:CreativeWork
257 https://www.grid.ac/institutes/grid.10392.39 schema:alternateName University of Tübingen
258 schema:name Department of Diagnostic and Interventional Radiology, Eberhard-Karls-University Tuebingen, Hoppe-Seyler-Strasse 3, 72076, Tuebingen, Germany
259 Department of Nuclear Medicine, Eberhard-Karls-University Tuebingen, Tuebingen, Germany
260 Skin Cancer Programme, Department of Dermatology, Eberhard-Karls-University Tuebingen, Tuebingen, Germany
261 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...